On Cancer Screening During the COVID-19 Pandemic.
作者信息
Brawley Otis W
机构信息
Department of Oncology, Department of Epidemiology, Johns Hopkins University, Baltimore, MD.
出版信息
J Clin Oncol. 2023 Sep 20;41(27):4338-4340. doi: 10.1200/JCO.23.00284. Epub 2023 Aug 9.
Abstract
摘要
相似文献
1
On Cancer Screening During the COVID-19 Pandemic.
J Clin Oncol. 2023 Sep 20;41(27):4338-4340. doi: 10.1200/JCO.23.00284. Epub 2023 Aug 9.
2
Cancer screening falls during the COVID-19 pandemic.
Cancer. 2022 Nov 1;128(21):3755. doi: 10.1002/cncr.34500.
3
Cancer screenings decline significantly during pandemic.
Cancer. 2020 Sep 1;126(17):3894-3895. doi: 10.1002/cncr.33128.
4
Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.
Cancer Cell. 2021 Aug 9;39(8):1042-1044. doi: 10.1016/j.ccell.2021.06.019. Epub 2021 Jul 1.
5
Impact of COVID-19 on cancer screening: a global perspective.
Curr Opin Support Palliat Care. 2022 Sep 1;16(3):102-109. doi: 10.1097/SPC.0000000000000602. Epub 2022 Jul 18.
6
The impact of the COVID-19 pandemic on cancer screening.
Eur J Cancer Prev. 2022 Sep 1;31(5):487-488. doi: 10.1097/CEJ.0000000000000720. Epub 2021 Aug 26.
7
Creating a healthy community after the pandemic: Reinvigorating routine cancer screening with community support systems.
Cancer. 2021 Dec 1;127(23):4365-4367. doi: 10.1002/cncr.33858. Epub 2021 Aug 26.
8
Re-engaging EU citizens with national screening programmes and cancer diagnosis post-pandemic.
Lancet Oncol. 2022 May;23(5):566-567. doi: 10.1016/S1470-2045(22)00090-0.
9
Routine cancer screening delays due to pandemic at veteran affairs.
J Natl Med Assoc. 2022 Feb;114(1):12-15. doi: 10.1016/j.jnma.2021.08.033. Epub 2021 Sep 8.
10
Implementation of Early Detection Services for Cancer in India During COVID-19 Pandemic.
Cancer Control. 2020 Jan-Dec;27(1):1073274820960471. doi: 10.1177/1073274820960471.
引用本文的文献
1
The impact of the COVID-19 pandemic on the diagnosis, treatment, and prognosis of ovarian cancer in the United States: a retrospective cohort study based on the SEER database.
Discov Oncol. 2025 Apr 17;16(1):545. doi: 10.1007/s12672-025-02205-y.
2
Impact of plasma Epstein-Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection.
Infect Agent Cancer. 2024 Mar 14;19(1):8. doi: 10.1186/s13027-024-00570-x.
本文引用的文献
1
Cancer Screening in the United States During the Second Year of the COVID-19 Pandemic.
J Clin Oncol. 2023 Sep 20;41(27):4352-4359. doi: 10.1200/JCO.22.02170. Epub 2023 Feb 23.
2
COVID-19 and cancer.
Science. 2020 Jun 19;368(6497):1290. doi: 10.1126/science.abd3377.
3
Current Prevalence of Major Cancer Risk Factors and Screening Test Use in the United States: Disparities by Education and Race/Ethnicity.
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):629-642. doi: 10.1158/1055-9965.EPI-18-1169.
Zotero 插件